[go: up one dir, main page]

GB201903005D0 - Compounds for treating multiple myeloma - Google Patents

Compounds for treating multiple myeloma

Info

Publication number
GB201903005D0
GB201903005D0 GBGB1903005.5A GB201903005A GB201903005D0 GB 201903005 D0 GB201903005 D0 GB 201903005D0 GB 201903005 A GB201903005 A GB 201903005A GB 201903005 D0 GB201903005 D0 GB 201903005D0
Authority
GB
United Kingdom
Prior art keywords
compounds
multiple myeloma
treating multiple
treating
myeloma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1903005.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mundipharma International Corp Ltd
Original Assignee
Mundipharma International Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma International Corp Ltd filed Critical Mundipharma International Corp Ltd
Priority to GBGB1903005.5A priority Critical patent/GB201903005D0/en
Publication of GB201903005D0 publication Critical patent/GB201903005D0/en
Priority to CA3124001A priority patent/CA3124001A1/en
Priority to US17/414,797 priority patent/US12377076B2/en
Priority to AU2019400983A priority patent/AU2019400983B2/en
Priority to CN201980084762.5A priority patent/CN113365625A/en
Priority to EP19835808.7A priority patent/EP3897626B1/en
Priority to US17/414,806 priority patent/US20220016085A1/en
Priority to PCT/IB2019/061034 priority patent/WO2020128912A1/en
Priority to PCT/IB2019/061035 priority patent/WO2020128913A1/en
Priority to CN201980084596.9A priority patent/CN113365624A/en
Priority to JP2021535307A priority patent/JP2022522928A/en
Priority to CA3124005A priority patent/CA3124005A1/en
Priority to KR1020217021704A priority patent/KR20210105380A/en
Priority to AU2019402158A priority patent/AU2019402158B2/en
Priority to EP19835807.9A priority patent/EP3897625A1/en
Priority to JP2021535301A priority patent/JP2022514048A/en
Ceased legal-status Critical Current

Links

GBGB1903005.5A 2018-12-18 2019-03-06 Compounds for treating multiple myeloma Ceased GB201903005D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1903005.5A GB201903005D0 (en) 2019-03-06 2019-03-06 Compounds for treating multiple myeloma
JP2021535301A JP2022514048A (en) 2018-12-18 2019-12-18 Compounds for treating lymphoma or T-cell malignancies
US17/414,806 US20220016085A1 (en) 2018-12-18 2019-12-18 Compounds for treating multiple myeloma
PCT/IB2019/061035 WO2020128913A1 (en) 2018-12-18 2019-12-18 Compounds for treating multiple myeloma
AU2019400983A AU2019400983B2 (en) 2018-12-18 2019-12-18 Compounds for treating multiple myeloma
CN201980084762.5A CN113365625A (en) 2018-12-18 2019-12-18 Compounds for the treatment of multiple myeloma
EP19835808.7A EP3897626B1 (en) 2018-12-18 2019-12-18 Tinostamustine for treating multiple myeloma
CA3124001A CA3124001A1 (en) 2018-12-18 2019-12-18 Compounds for treating lymphoma or a t-cell malignant disease
PCT/IB2019/061034 WO2020128912A1 (en) 2018-12-18 2019-12-18 Compounds for treating lymphoma or a t-cell malignant disease
US17/414,797 US12377076B2 (en) 2018-12-18 2019-12-18 Compounds for treating lymphoma or a T-cell malignant disease
CN201980084596.9A CN113365624A (en) 2018-12-18 2019-12-18 Compounds for the treatment of lymphoma or T-cell malignancies
JP2021535307A JP2022522928A (en) 2018-12-18 2019-12-18 Compounds for treating multiple myeloma
CA3124005A CA3124005A1 (en) 2018-12-18 2019-12-18 Compounds for treating multiple myeloma
KR1020217021704A KR20210105380A (en) 2018-12-18 2019-12-18 Compounds for treating multiple myeloma
AU2019402158A AU2019402158B2 (en) 2018-12-18 2019-12-18 Compounds for treating lymphoma or a T-cell malignant disease
EP19835807.9A EP3897625A1 (en) 2018-12-18 2019-12-18 Compounds for treating lymphoma or a t-cell malignant disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1903005.5A GB201903005D0 (en) 2019-03-06 2019-03-06 Compounds for treating multiple myeloma

Publications (1)

Publication Number Publication Date
GB201903005D0 true GB201903005D0 (en) 2019-04-17

Family

ID=66377429

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1903005.5A Ceased GB201903005D0 (en) 2018-12-18 2019-03-06 Compounds for treating multiple myeloma

Country Status (1)

Country Link
GB (1) GB201903005D0 (en)

Similar Documents

Publication Publication Date Title
IL285110A (en) Methods for treating multiple myeloma
GB201905721D0 (en) Compounds
GB201910305D0 (en) Compounds
IL323990A (en) Methods for treating multiple myeloma
IL323989A (en) Methods for treating multiple myeloma
GB201909468D0 (en) Compounds for treating cancer
GB201916915D0 (en) Compounds
GB201908536D0 (en) Compounds
IL290319A (en) Compound for combination treatment
IL284668A (en) Methods for treating schizophrenia
GB201910304D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
GB201908436D0 (en) Compounds for treating multiple myeloma
GB201903005D0 (en) Compounds for treating multiple myeloma
GB201909466D0 (en) Compounds for treating cancer
GB201820643D0 (en) Compounds for treating multiple myeloma
IL285800A (en) Method for treating a multiple myeloma
GB202007652D0 (en) Compounds for treating covid-19
GB201916150D0 (en) Treatment of multiple myeloma
HK40065723A (en) Method for treating a multiple myeloma
GB201917893D0 (en) Compounds
GB201917891D0 (en) Compounds
GB201916847D0 (en) Compounds
GB201916572D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)